fenofibrate has been researched along with Syndrome in 5 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our objective was to determine whether fenofibrate modifies the metabolism of nonesterified (free) fatty acids as a component of its triglyceride-lowering action in male patients with the metabolic syndrome." | 9.10 | Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. ( Cater, NB; Grundy, SM; Hadizadeh, DR; Meguro, S; Vega, GL, 2003) |
| "Our objective was to determine whether fenofibrate modifies the metabolism of nonesterified (free) fatty acids as a component of its triglyceride-lowering action in male patients with the metabolic syndrome." | 5.10 | Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. ( Cater, NB; Grundy, SM; Hadizadeh, DR; Meguro, S; Vega, GL, 2003) |
| "This syndrome is a pathological entity of low incidence which mainly affects high density lipoprotein (HDL) metabolism." | 1.30 | [Partial lecithin-cholesterol acyltransferase (LCAT) deficiency syndrome]. ( Brites, FD; Castro, GR; Fernández, KM; Lardo, M; Wikinski, RL; Yael, MJ; Zunino, MJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vega, GL | 1 |
| Cater, NB | 1 |
| Hadizadeh, DR | 1 |
| Meguro, S | 1 |
| Grundy, SM | 1 |
| Conaway, DG | 1 |
| O'Keefe, JH | 1 |
| Gresser, U | 1 |
| Gathof, BS | 1 |
| Gross, M | 1 |
| Brites, FD | 1 |
| Fernández, KM | 1 |
| Zunino, MJ | 1 |
| Yael, MJ | 1 |
| Lardo, M | 1 |
| Castro, GR | 1 |
| Wikinski, RL | 1 |
| Yong, QW | 1 |
| Thavintharan, S | 1 |
| Cheng, A | 1 |
| Chew, LS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome. A Randomized, Double-Blind, Placebo-Controlled Trial[NCT00884819] | 4 participants (Actual) | Interventional | 2008-12-31 | Terminated (stopped due to Poor recruitment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fenofibrate and Syndrome
| Article | Year |
|---|---|
Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes.
Topics: Angina, Unstable; Blood Glucose; Comorbidity; Diabetes Mellitus; Diabetic Angiopathies; Fenofibrate; | 2006 |
1 trial available for fenofibrate and Syndrome
| Article | Year |
|---|---|
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Topics: Adipose Tissue; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Fatty Acids, Nonesterified; Fenofi | 2003 |
3 other studies available for fenofibrate and Syndrome
| Article | Year |
|---|---|
Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
Topics: Benzbromarone; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Gout; Humans; Hyperlipi | 1994 |
[Partial lecithin-cholesterol acyltransferase (LCAT) deficiency syndrome].
Topics: Cholesterol, HDL; Female; Fenofibrate; Humans; Lecithin Cholesterol Acyltransferase Deficiency; Midd | 1999 |
The effect of fenofibrate on insulin sensitivity and plasma lipid profile in non-diabetic males with low high density lipoprotein/dyslipidaemic syndrome.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Glucose Tolerance Test; Humans; Hyperlipidem | 1999 |